The Irish Medicines Board (IMB) has issued a warning regarding the potential for hepatic (liver) failure and serious skin reactions for patients using the drug Avelox. Avelox is the brand name for the drug Moxifloxacin Hydrochloride which was developed by German pharmaceutical company Bayer AG. This prescription medication is used to treat bacterial infections but only in limited circumstances when other antibiotics have failed. Avelox is a drug of last resort because it interacts with other drugs and even herbal supplements.
Safety Review Concerning the Drug
Following recent European reviews regarding the risk of serious side effects associated with the use of Avelox, the IMB announced that healthcare professionals should be aware of the dangerous side effects associated with the use of the drug to include severe skin reactions and liver failure. The labelling information has now been updated to include severe liver failure and serious skin reactions as known side effects of the medication. It has also been reported to cause Toxic Epidermal Necrolysis (TEN) also known as Lyell-s Syndrome.
What is Toxic Epidermal Necrolysis?
This is a life threatening dermatological condition that is frequently induced by a reaction to medication. It causes the detachment of the top layer of skin (the epidermis) from the lower layers of the skin (the dermis) all over the body.
If you have taken Avelox and believe it has harmed you, contact Liam Moloney, Solicitor, Naas today on 045 898000 for a free confidential legal consultation. He will evaluate your case on the basis of the principles of negligence and product liability.
There is a limitation period that applies to these types of claims so it is extremely important that you immediately contact a Solicitor as soon as possible as failure to do so may result in your case becoming time barred.